The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis
出版年份 2014 全文链接
标题
The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 10, Pages 2685-2703
出版商
Wiley
发表日期
2014-01-28
DOI
10.1111/bph.12608
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Essential role of interleukin-6 in post-stroke angiogenesis
- (2012) Karen Gertz et al. BRAIN
- Comparative Molecular Profiling of the PPARα/γ Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors
- (2012) Michel Dietz et al. ChemMedChem
- Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use
- (2012) Gian Paolo Fadini et al. CIRCULATION RESEARCH
- From Bench to Bedside: What Physicians Need to Know About Endothelial Progenitor Cells
- (2011) Mayr Matthias et al. AMERICAN JOURNAL OF MEDICINE
- Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis
- (2011) Christian Werner et al. ATHEROSCLEROSIS
- Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome
- (2011) Barbara C Hansen et al. Cardiovascular Diabetology
- Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
- (2011) Jing Li et al. Cardiovascular Diabetology
- Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis
- (2011) Stephan H. Schirmer et al. EUROPEAN HEART JOURNAL
- Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis
- (2011) Anja M. van der Laan et al. EUROPEAN HEART JOURNAL
- Effects of DPP-4 inhibition on cardiac metabolism and function in mice
- (2011) M. Lenski et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Therapeutic Potential of Aleglitazar, a New Dual PPAR-α/γ Agonist
- (2010) Matthew A. Cavender et al. American Journal of Cardiovascular Drugs
- Regulation of Bone Marrow-Derived Vascular Progenitor Cell Mobilization and Maintenance
- (2010) Stefanie Dimmeler ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice
- (2010) Janine Pöss et al. BASIC RESEARCH IN CARDIOLOGY
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2
- (2010) Saher Hamed et al. CARDIOVASCULAR RESEARCH
- The Promise of Cell-Based Therapies for Diabetic Complications
- (2010) Yagna P.R. Jarajapu et al. CIRCULATION RESEARCH
- Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patients With Type 2 Diabetes: Results From a Randomized, Placebo-Controlled Clinical Study
- (2010) P Sanwald-Ducray et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of high dose aleglitazar on renal function in patients with type 2 diabetes
- (2010) Matthias Herz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- PPARα Is Essential for Microparticle-Induced Differentiation of Mouse Bone Marrow-Derived Endothelial Progenitor Cells and Angiogenesis
- (2010) Tarek Benameur et al. PLoS One
- Peroxisome Proliferator-Activated Receptor Alpha Target Genes
- (2010) Maryam Rakhshandehroo et al. PPAR Research
- Aleglitazar, a new, potent, and balanced dual PPARα/γ agonist for the treatment of type II diabetes
- (2009) Agnes Bénardeau et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall
- (2009) Christian Werner et al. CIRCULATION
- Stimulation of collateral artery growth: travelling further down the road to clinical application
- (2009) S H Schirmer et al. HEART
- PPAR-α and PPAR-γ agonists for type 2 diabetes
- (2009) Bernard Charbonnel LANCET
- Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
- (2009) Robert R Henry et al. LANCET
- Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice
- (2008) Florian Custodis et al. CIRCULATION
- Rapid Endothelial Turnover in Atherosclerosis-Prone Areas Coincides With Stem Cell Repair in Apolipoprotein E–Deficient Mice
- (2008) Georgios Foteinos et al. CIRCULATION
- Interferon-β Signaling Is Enhanced in Patients With Insufficient Coronary Collateral Artery Development and Inhibits Arteriogenesis in Mice
- (2008) Stephan H. Schirmer et al. CIRCULATION RESEARCH
- Effects of Physical Exercise on Myocardial Telomere-Regulating Proteins, Survival Pathways, and Apoptosis
- (2008) Christian Werner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started